Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Recommendations
Nevro successfully defended exclusive SCS ability, says Piper Sandler » 09:43
08/01/22
08/01
09:43
08/01/22
09:43
NVRO

Nevro

$43.29 /

+0.01 (+0.02%)

, BSX

Boston Scientific

$41.06 /

+0.005 (+0.01%)

Nevro (NVRO) and Boston…

Nevro (NVRO) and Boston Scientific (BSX) announced that they have reached a settlement in the ongoing intellectual property litigation regarding spinal cord stimulation technology therapy, which brings a close to the multi-year litigation between the parties, Piper Sandler analyst Adam Maeder tells investors in a research note. The settlement gives Boston Scientific the freedom to operate below 1,500Hz using the features/capabilities in its current product offerings, while Nevro has freedom to operate using the features/capabilities in its current product lines, says the analyst. He believes Nevro has successfully defended its exclusive ability to use high-frequency stimulation and notes it remains the only SCS player able to legally use frequencies above 1,500Hz. Maeder keeps a Neutral rating on the shares with a $64 price target.

ShowHide Related Items >><<
NVRO Nevro
$43.29 /

+0.01 (+0.02%)

BSX Boston Scientific
$41.06 /

+0.005 (+0.01%)

NVRO Nevro
$43.29 /

+0.01 (+0.02%)

05/26/22 JMP Securities
Nevro price target lowered to $95 from $125 at JMP Securities
05/17/22 Citi
Nevro price target lowered to $68 from $78 at Citi
05/05/22 Citi
Nevro upgraded to Buy from Neutral at Citi
05/05/22 Piper Sandler
Nevro price target lowered to $64 from $65 at Piper Sandler
BSX Boston Scientific
$41.06 /

+0.005 (+0.01%)

07/28/22 Canaccord
Boston Scientific price target raised to $45 from $43 at Canaccord
07/28/22 BTIG
Boston Scientific price target raised to $50 from $45 at BTIG
07/27/22 Piper Sandler
Piper trims Boston Scientific target, says stock 'a crowded long for a reason'
07/20/22 Truist
Boston Scientific price target lowered to $45 from $51 at Truist
NVRO Nevro
$43.29 /

+0.01 (+0.02%)

BSX Boston Scientific
$41.06 /

+0.005 (+0.01%)

NVRO Nevro
$43.29 /

+0.01 (+0.02%)

BSX Boston Scientific
$41.06 /

+0.005 (+0.01%)

BSX Boston Scientific
$41.06 /

+0.005 (+0.01%)

Hot Stocks
Nevro, Boston Scientific settle ongoing intellectual property litigations » 07:02
08/01/22
08/01
07:02
08/01/22
07:02
NVRO

Nevro

$43.29 /

-1.51 (-3.37%)

, BSX

Boston Scientific

$41.06 /

-0.115 (-0.28%)

Nevro (NVRO) and Boston…

Nevro (NVRO) and Boston Scientific (BSX) announced that they have reached a settlement in their ongoing intellectual property litigations that gives Boston Scientific the freedom to operate using the features and capabilities embodied in its current line of products for frequencies below 1,500 Hz, and gives Nevro the freedom to operate using the features and capabilities embodied in its current line of products. Nevro will grant Boston Scientific a worldwide, non-exclusive, non-transferable license to practice paresthesia-free therapy at frequencies below 1,500 Hz and a covenant not to sue for any features embodied in any current Boston Scientific products for frequencies below 1,500 Hz. Boston Scientific also will grant Nevro a worldwide, non-exclusive, non-transferable license under Boston Scientific's asserted patent families and a covenant not to sue for any features embodied in any current Nevro products. This settlement concludes all of the existing litigations between Nevro and Boston Scientific, and includes a net payment from Boston Scientific to Nevro of $85M.

ShowHide Related Items >><<
NVRO Nevro
$43.29 /

-1.51 (-3.37%)

BSX Boston Scientific
$41.06 /

-0.115 (-0.28%)

NVRO Nevro
$43.29 /

-1.51 (-3.37%)

05/26/22 JMP Securities
Nevro price target lowered to $95 from $125 at JMP Securities
05/17/22 Citi
Nevro price target lowered to $68 from $78 at Citi
05/05/22 Citi
Nevro upgraded to Buy from Neutral at Citi
05/05/22 Piper Sandler
Nevro price target lowered to $64 from $65 at Piper Sandler
BSX Boston Scientific
$41.06 /

-0.115 (-0.28%)

07/28/22 Canaccord
Boston Scientific price target raised to $45 from $43 at Canaccord
07/28/22 BTIG
Boston Scientific price target raised to $50 from $45 at BTIG
07/27/22 Piper Sandler
Piper trims Boston Scientific target, says stock 'a crowded long for a reason'
07/20/22 Truist
Boston Scientific price target lowered to $45 from $51 at Truist
NVRO Nevro
$43.29 /

-1.51 (-3.37%)

BSX Boston Scientific
$41.06 /

-0.115 (-0.28%)

NVRO Nevro
$43.29 /

-1.51 (-3.37%)

BSX Boston Scientific
$41.06 /

-0.115 (-0.28%)

BSX Boston Scientific
$41.06 /

-0.115 (-0.28%)

Recommendations
Boston Scientific price target raised to $45 from $43 at Canaccord » 07:31
07/28/22
07/28
07:31
07/28/22
07:31
BSX

Boston Scientific

$40.30 /

+2.305 (+6.07%)

Canaccord analyst William…

Canaccord analyst William Plovanic raised the firm's price target on Boston Scientific to $45 from $43 and keeps a Buy rating on the shares. The analyst continues to stick to his thesis, that Watchman, Farapulse, and Acurate neo2 will drive future growth for the company.

ShowHide Related Items >><<
BSX Boston Scientific
$40.30 /

+2.305 (+6.07%)

BSX Boston Scientific
$40.30 /

+2.305 (+6.07%)

07/28/22 BTIG
Boston Scientific price target raised to $50 from $45 at BTIG
07/27/22 Piper Sandler
Piper trims Boston Scientific target, says stock 'a crowded long for a reason'
07/20/22 Truist
Boston Scientific price target lowered to $45 from $51 at Truist
07/06/22 Wolfe Research
Wolfe Research starts 'Goldilocks stock' Boston Scientific at Outperform
BSX Boston Scientific
$40.30 /

+2.305 (+6.07%)

BSX Boston Scientific
$40.30 /

+2.305 (+6.07%)

BSX Boston Scientific
$40.30 /

+2.305 (+6.07%)

Recommendations
Boston Scientific price target raised to $50 from $45 at BTIG » 06:19
07/28/22
07/28
06:19
07/28/22
06:19
BSX

Boston Scientific

$40.30 /

+2.305 (+6.07%)

BTIG analyst Marie…

BTIG analyst Marie Thibault raised the firm's price target on Boston Scientific to $50 from $45 and keeps a Buy rating on the shares. The company's Q2 results were "solid" as management also boosted its outlook for organic sales growth, the analyst tells investors in a research note. Thibault further cites Boston Scientific commentary as "more encouraging" than that of other large-cap MedTech peers, with management citing strong global execution during Q2 and calling for an acceleration in the second half of the year despite hospital staffing challenges.

ShowHide Related Items >><<
BSX Boston Scientific
$40.30 /

+2.305 (+6.07%)

BSX Boston Scientific
$40.30 /

+2.305 (+6.07%)

07/27/22 Piper Sandler
Piper trims Boston Scientific target, says stock 'a crowded long for a reason'
07/20/22 Truist
Boston Scientific price target lowered to $45 from $51 at Truist
07/06/22 Wolfe Research
Wolfe Research starts 'Goldilocks stock' Boston Scientific at Outperform
07/05/22 Wolfe Research
Boston Scientific initiated with an Outperform at Wolfe Research
BSX Boston Scientific
$40.30 /

+2.305 (+6.07%)

BSX Boston Scientific
$40.30 /

+2.305 (+6.07%)

BSX Boston Scientific
$40.30 /

+2.305 (+6.07%)

Recommendations
Piper trims Boston Scientific target, says stock 'a crowded long for a reason' » 13:20
07/27/22
07/27
13:20
07/27/22
13:20
BSX

Boston Scientific

$39.88 /

+1.885 (+4.96%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien lowered the firm's price target on Boston Scientific to $47 from $50 and keeps an Overweight rating on the shares after the company reported Q2 sales and EPS ahead of expectations, raised its yearly organic revenue growth guidance "slightly" and "largely maintained" its EPS outlook. Though he trimmed his target on the shares to reflect next year's earnings and multiple compression in large cap medtech, O'Brien contends that Boston Scientific is "a crowded long for a reason" and calls it his "favorite diversified, large cap name" among his medical technology and devices coverage.

ShowHide Related Items >><<
BSX Boston Scientific
$39.88 /

+1.885 (+4.96%)

BSX Boston Scientific
$39.88 /

+1.885 (+4.96%)

07/20/22 Truist
Boston Scientific price target lowered to $45 from $51 at Truist
07/06/22 Wolfe Research
Wolfe Research starts 'Goldilocks stock' Boston Scientific at Outperform
07/05/22 Wolfe Research
Boston Scientific initiated with an Outperform at Wolfe Research
07/05/22 Piper Sandler
Bottom in med tech shares is 'getting close,' says Piper Sandler
BSX Boston Scientific
$39.88 /

+1.885 (+4.96%)

BSX Boston Scientific
$39.88 /

+1.885 (+4.96%)

BSX Boston Scientific
$39.88 /

+1.885 (+4.96%)

On The Fly
Fly Intel: Pre-market Movers » 09:20
07/27/22
07/27
09:20
07/27/22
09:20
TEVA

Teva

$7.13 /

-0.06 (-0.84%)

, TMUS

T-Mobile

$133.91 /

-0.62 (-0.46%)

, BA

Boeing

$155.81 /

-0.87 (-0.56%)

, ADP

ADP

$217.89 /

-0.39 (-0.18%)

, BSX

Boston Scientific

$38.00 /

-0.02 (-0.05%)

, HLT

Hilton

$120.40 /

-1.775 (-1.45%)

, CMG

Chipotle

$1,317.61 /

-11.955 (-0.90%)

, MSFT

Microsoft

$251.82 /

-6.92 (-2.67%)

, GOOG

Alphabet

$105.45 /

-2.72 (-2.51%)

, GOOGL

Alphabet

$104.83 /

-2.73 (-2.54%)

, BMY

Bristol-Myers

$73.51 /

+0.68 (+0.93%)

, SHW

Sherwin-Williams

$254.36 /

-4.63 (-1.79%)

, GD

General Dynamics

$217.48 /

-1.32 (-0.60%)

, HUM

Humana

$491.17 /

-0.69 (-0.14%)

, SHOP

Shopify

$31.54 /

-5.17 (-14.08%)

, TPX

Tempur Sealy

$24.17 /

-0.83 (-3.32%)

, OBSV

ObsEva

$1.62 /

+0.01 (+0.62%)

, FXLV

F45 Training

$3.52 /

-0.22 (-5.88%)

Check out this morning's…

ShowHide Related Items >><<
TPX Tempur Sealy
$24.17 /

-0.83 (-3.32%)

TMUS T-Mobile
$133.91 /

-0.62 (-0.46%)

TEVA Teva
$7.13 /

-0.06 (-0.84%)

SHW Sherwin-Williams
$254.36 /

-4.63 (-1.79%)

SHOP Shopify
$31.54 /

-5.17 (-14.08%)

OBSV ObsEva
$1.62 /

+0.01 (+0.62%)

MSFT Microsoft
$251.82 /

-6.92 (-2.67%)

HUM Humana
$491.17 /

-0.69 (-0.14%)

HLT Hilton
$120.40 /

-1.775 (-1.45%)

GOOG Alphabet
$105.45 /

-2.72 (-2.51%)

GD General Dynamics
$217.48 /

-1.32 (-0.60%)

FXLV F45 Training
$3.52 /

-0.22 (-5.88%)

CMG Chipotle
$1,317.61 /

-11.955 (-0.90%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BMY Bristol-Myers
$73.51 /

+0.68 (+0.93%)

BA Boeing
$155.81 /

-0.87 (-0.56%)

ADP ADP
$217.89 /

-0.39 (-0.18%)

TEVA Teva
$7.13 /

-0.06 (-0.84%)

07/27/22 Cantor Fitzgerald
Teva settlement brings uncertainty to Emergent shares, says Cantor Fitzgerald
06/13/22 UBS
Teva initiated with a Neutral at UBS
06/13/22 UBS
Teva initiated with a Neutral at UBS
05/17/22 BofA
Teva upgraded to Neutral at BofA on potential opioid deal upside
TMUS T-Mobile
$133.91 /

-0.62 (-0.46%)

07/22/22 Barclays
AT&T downgraded to Equal Weight from Overweight at Barclays
07/20/22 Citi
T-Mobile price target raised to $160 from $156 at Citi
07/19/22 Deutsche Bank
T-Mobile price target raised to $190 from $185 at Deutsche Bank
07/14/22 RBC Capital
T-Mobile price target raised to $158 from $152 at RBC Capital
BA Boeing
$155.81 /

-0.87 (-0.56%)

07/18/22 Cowen
Cowen believes Aerospace and Defense quarterly results to be mixed
07/15/22 Benchmark
Boeing price target lowered to $200 from $250 at Benchmark
07/14/22 RBC Capital
Boeing price target lowered to $200 from $220 at RBC Capital
07/13/22 JPMorgan
Boeing price target lowered to $188 from $190 at JPMorgan
ADP ADP
$217.89 /

-0.39 (-0.18%)

07/20/22 Wolfe Research
ADP price target lowered to $210 from $235 at Wolfe Research
05/02/22 Mizuho
ADP price target raised to $250 from $235 at Mizuho
05/02/22 Barclays
ADP price target raised to $257 from $238 at Barclays
05/02/22 Citi
ADP price target raised to $230 from $212 at Citi
BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

07/20/22 Truist
Boston Scientific price target lowered to $45 from $51 at Truist
07/06/22 Wolfe Research
Wolfe Research starts 'Goldilocks stock' Boston Scientific at Outperform
07/05/22 Wolfe Research
Boston Scientific initiated with an Outperform at Wolfe Research
07/05/22 Piper Sandler
Bottom in med tech shares is 'getting close,' says Piper Sandler
HLT Hilton
$120.40 /

-1.775 (-1.45%)

07/11/22 Evercore ISI
Hilton assumed at Outperform from In Line at Evercore ISI
06/28/22 Barclays
Hilton initiated with an Equal Weight at Barclays
05/04/22 Deutsche Bank
Hilton price target raised to $141 from $136 at Deutsche Bank
02/22/22 Wells Fargo
Hilton price target raised to $160 from $147 at Wells Fargo
CMG Chipotle
$1,317.61 /

-11.955 (-0.90%)

07/27/22 BTIG
Chipotle price target lowered to $1,825 from $1,975 at BTIG
07/27/22 Cowen
Chipotle price target lowered to $1600 from $1830 at Cowen
07/27/22 Deutsche Bank
Chipotle price target lowered to $1,503 from $1,505 at Deutsche Bank
07/27/22 Morgan Stanley
Chipotle price target raised to $1,808 from $1,768 at Morgan Stanley
MSFT Microsoft
$251.82 /

-6.92 (-2.67%)

07/27/22 Wedbush
Microsoft price target lowered to $320 from $340 at Wedbush
07/27/22 Cowen
Microsoft price target lowered to $320 from $330 at Cowen
07/27/22 Deutsche Bank
Microsoft price target lowered to $330 from $350 at Deutsche Bank
07/27/22 JPMorgan
Microsoft price target lowered to $305 from $320 at JPMorgan
GOOG Alphabet
$105.45 /

-2.72 (-2.51%)

07/27/22 Susquehanna
Alphabet price target lowered to $150 from $187 at Susquehanna
07/27/22 Evercore ISI
Alphabet price target lowered to $140 from $155.50 at Evercore ISI
07/27/22 Jefferies
Alphabet price target lowered to $130 from $155 at Jefferies
07/27/22 Wells Fargo
Alphabet price target lowered to $160 from $170 at Wells Fargo
GOOGL Alphabet
$104.83 /

-2.73 (-2.54%)

07/27/22 Raymond James
Alphabet price target lowered to $143 from $159 at Raymond James
BMY Bristol-Myers
$73.51 /

+0.68 (+0.93%)

07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
06/23/22 BMO Capital
Nuvalent initiated with an Outperform at BMO Capital
06/06/22 H.C. Wainwright
Turning Point Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
06/05/22 BofA
BofA keeps Buy on Bristol-Myers, raises price target to $80
SHW Sherwin-Williams
$254.36 /

-4.63 (-1.79%)

07/18/22 Wells Fargo
Sherwin-Williams price target lowered to $270 from $285 at Wells Fargo
07/14/22 Mizuho
Sherwin-Williams price target lowered to $294 from $310 at Mizuho
07/13/22 BofA
BofA downgrades Sherwin-Williams to Neutral, sees limited catalysts
07/13/22 BofA
Sherwin-Williams downgraded to Neutral from Buy at BofA
GD General Dynamics
$217.48 /

-1.32 (-0.60%)

04/28/22 Susquehanna
General Dynamics price target raised to $285 from $280 at Susquehanna
03/29/22 Jefferies
Northrop among biggest beneficiaries of DoD budget request, says Jefferies
03/07/22 Wells Fargo
General Dynamics price target raised to $282 from $235 at Wells Fargo
02/04/22 Morgan Stanley
Morgan Stanley upgrades General Dynamics to Equal Weight on Gulfstream outlook
HUM Humana
$491.17 /

-0.69 (-0.14%)

07/14/22 Truist
Humana price target raised to $550 from $490 at Truist
07/05/22 Stifel
Stifel says 'logical to assume' Walgreens could look at 1Life Healthcare
06/16/22 Loop Capital
Loop starts Humana at Buy on brand and growing portfolio
06/16/22 Loop Capital
Humana initiated with a Buy at Loop Capital
SHOP Shopify
$31.54 /

-5.17 (-14.08%)

07/26/22 Oppenheimer
Shopify assumed with an Outperform at Oppenheimer
07/26/22 Stifel
BigCommerce price target lowered to $23 from $35 at Stifel
07/26/22 Citi
Shopify price target lowered to $37 from $43.20 at Citi
07/18/22 Wells Fargo
Shopify price target lowered to $40 from $55 at Wells Fargo
TPX Tempur Sealy
$24.17 /

-0.83 (-3.32%)

07/20/22 UBS
Tempur Sealy price target lowered to $35 from $45 at UBS
06/01/22 Piper Sandler
Tempur Sealy downgraded to Neutral from Overweight at Piper Sandler
04/12/22 Loop Capital
Tempur Sealy price target lowered to $28 from $35 at Loop Capital
04/06/22 Raymond James
Tempur Sealy price target lowered to $38 from $45 at Raymond James
OBSV ObsEva
$1.62 /

+0.01 (+0.62%)

06/03/22 Cantor Fitzgerald
ObsEva initiated with an Overweight at Cantor Fitzgerald
04/26/22 Canaccord
ObsEva initiated with a Buy at Canaccord
03/28/22 Aegis
ObsEva initiated with a Buy at Aegis
03/28/22 H.C. Wainwright
ObsEva price target lowered to $11 from $15 at H.C. Wainwright
FXLV F45 Training
$3.52 /

-0.22 (-5.88%)

07/27/22 Baird
Baird downgrades F45 Training to Neutral, slashes target to $2
07/27/22 Baird
F45 Training downgraded to Neutral from Outperform at Baird
07/27/22 Macquarie
F45 Training downgraded to Neutral from Outperform at Macquarie
06/13/22 Jefferies
Jefferies names five top picks in lifestyle and growth platforms
TPX Tempur Sealy
$24.17 /

-0.83 (-3.32%)

TMUS T-Mobile
$133.91 /

-0.62 (-0.46%)

TEVA Teva
$7.13 /

-0.06 (-0.84%)

SHW Sherwin-Williams
$254.36 /

-4.63 (-1.79%)

SHOP Shopify
$31.54 /

-5.17 (-14.08%)

OBSV ObsEva
$1.62 /

+0.01 (+0.62%)

MSFT Microsoft
$251.82 /

-6.92 (-2.67%)

HUM Humana
$491.17 /

-0.69 (-0.14%)

HLT Hilton
$120.40 /

-1.775 (-1.45%)

GOOG Alphabet
$105.45 /

-2.72 (-2.51%)

GD General Dynamics
$217.48 /

-1.32 (-0.60%)

FXLV F45 Training
$3.52 /

-0.22 (-5.88%)

CMG Chipotle
$1,317.61 /

-11.955 (-0.90%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BMY Bristol-Myers
$73.51 /

+0.68 (+0.93%)

BA Boeing
$155.81 /

-0.87 (-0.56%)

ADP ADP
$217.89 /

-0.39 (-0.18%)

  • 09
    Sep
TMUS T-Mobile
$133.91 /

-0.62 (-0.46%)

TEVA Teva
$7.13 /

-0.06 (-0.84%)

SHOP Shopify
$31.54 /

-5.17 (-14.08%)

MSFT Microsoft
$251.82 /

-6.92 (-2.67%)

HUM Humana
$491.17 /

-0.69 (-0.14%)

HLT Hilton
$120.40 /

-1.775 (-1.45%)

GOOG Alphabet
$105.45 /

-2.72 (-2.51%)

GD General Dynamics
$217.48 /

-1.32 (-0.60%)

CMG Chipotle
$1,317.61 /

-11.955 (-0.90%)

BMY Bristol-Myers
$73.51 /

+0.68 (+0.93%)

BA Boeing
$155.81 /

-0.87 (-0.56%)

TPX Tempur Sealy
$24.17 /

-0.83 (-3.32%)

TMUS T-Mobile
$133.91 /

-0.62 (-0.46%)

TEVA Teva
$7.13 /

-0.06 (-0.84%)

SHW Sherwin-Williams
$254.36 /

-4.63 (-1.79%)

SHOP Shopify
$31.54 /

-5.17 (-14.08%)

OBSV ObsEva
$1.62 /

+0.01 (+0.62%)

MSFT Microsoft
$251.82 /

-6.92 (-2.67%)

HUM Humana
$491.17 /

-0.69 (-0.14%)

HLT Hilton
$120.40 /

-1.775 (-1.45%)

GOOG Alphabet
$105.45 /

-2.72 (-2.51%)

GD General Dynamics
$217.48 /

-1.32 (-0.60%)

FXLV F45 Training
$3.52 /

-0.22 (-5.88%)

CMG Chipotle
$1,317.61 /

-11.955 (-0.90%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BMY Bristol-Myers
$73.51 /

+0.68 (+0.93%)

BA Boeing
$155.81 /

-0.87 (-0.56%)

ADP ADP
$217.89 /

-0.39 (-0.18%)

TPX Tempur Sealy
$24.17 /

-0.83 (-3.32%)

TMUS T-Mobile
$133.91 /

-0.62 (-0.46%)

TEVA Teva
$7.13 /

-0.06 (-0.84%)

SHW Sherwin-Williams
$254.36 /

-4.63 (-1.79%)

SHOP Shopify
$31.54 /

-5.17 (-14.08%)

MSFT Microsoft
$251.82 /

-6.92 (-2.67%)

HLT Hilton
$120.40 /

-1.775 (-1.45%)

GOOGL Alphabet
$104.83 /

-2.73 (-2.54%)

GOOG Alphabet
$105.45 /

-2.72 (-2.51%)

CMG Chipotle
$1,317.61 /

-11.955 (-0.90%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BMY Bristol-Myers
$73.51 /

+0.68 (+0.93%)

BA Boeing
$155.81 /

-0.87 (-0.56%)

Earnings
Boston Scientific cuts FY22 adjusted EPS view to $1.74-$1.77 from $1.74-$1.79 » 06:43
07/27/22
07/27
06:43
07/27/22
06:43
BSX

Boston Scientific

$38.00 /

-0.02 (-0.05%)

Consensus $1.76. Cuts…

Consensus $1.76. Cuts FY22 revenue view to up 6%-8% from up 7%-9%, consensus $12.82B. The company said, "The company now estimates net sales growth for the full year 2022, versus the prior year period, to be in a range of approximately 6.5 to 7.5 percent on a reported basis, and approximately 8 to 9 percent on an organic basis. Full year organic net sales guidance excludes the impact of foreign currency fluctuations and net sales attributable to acquisitions and divestitures for which there are less than a full period of comparable net sales. The company now estimates EPS on a GAAP basis in a range of $0.69 to $0.76 and estimates adjusted EPS, excluding certain charges (credits), of $1.74 to $1.77."

ShowHide Related Items >><<
BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

07/20/22 Truist
Boston Scientific price target lowered to $45 from $51 at Truist
07/06/22 Wolfe Research
Wolfe Research starts 'Goldilocks stock' Boston Scientific at Outperform
07/05/22 Wolfe Research
Boston Scientific initiated with an Outperform at Wolfe Research
07/05/22 Piper Sandler
Bottom in med tech shares is 'getting close,' says Piper Sandler
BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

Earnings
Boston Scientific sees Q3 adjusted EPS 43c-45c, consensus 45c » 06:39
07/27/22
07/27
06:39
07/27/22
06:39
BSX

Boston Scientific

$38.00 /

-0.02 (-0.05%)

Sees Q3 revenue up 6%-8%,…

Sees Q3 revenue up 6%-8%, consensus $3.2B. The company said, "The company estimates net sales growth for the third quarter of 2022, versus the prior year period, to be in a range of approximately 6 to 8 percent on a reported basis, and approximately 8 to 10 percent on an organic basis. Third quarter organic net sales guidance excludes the impact of foreign currency fluctuations and net sales attributable to acquisitions and divestitures for which there are less than a full period of comparable net sales. The company estimates EPS on a GAAP basis in a range of $0.20 to $0.24 and adjusted EPS, excluding certain charges (credits), of $0.43 to $0.45."

ShowHide Related Items >><<
BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

07/20/22 Truist
Boston Scientific price target lowered to $45 from $51 at Truist
07/06/22 Wolfe Research
Wolfe Research starts 'Goldilocks stock' Boston Scientific at Outperform
07/05/22 Wolfe Research
Boston Scientific initiated with an Outperform at Wolfe Research
07/05/22 Piper Sandler
Bottom in med tech shares is 'getting close,' says Piper Sandler
BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

Earnings
Boston Scientific reports Q2 adjusted EPS 44c, consensus 42c » 06:37
07/27/22
07/27
06:37
07/27/22
06:37
BSX

Boston Scientific

$38.00 /

-0.02 (-0.05%)

Reports Q2 revenue…

Reports Q2 revenue $3.24B, consensus $3.22B. "We had another quarter of excellent performance, a testament to the talent of our global team, the sustainability and diversification of our innovative medical technology portfolio and our strong market positions amid continued macroeconomic challenges," said Mike Mahoney, chairman and chief executive officer, Boston Scientific. "As we continue to execute our strategy, we have a tremendous opportunity to continue to deliver on our promise to bring life-changing devices and therapies to more patients who need them."

ShowHide Related Items >><<
BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

07/20/22 Truist
Boston Scientific price target lowered to $45 from $51 at Truist
07/06/22 Wolfe Research
Wolfe Research starts 'Goldilocks stock' Boston Scientific at Outperform
07/05/22 Wolfe Research
Boston Scientific initiated with an Outperform at Wolfe Research
07/05/22 Piper Sandler
Bottom in med tech shares is 'getting close,' says Piper Sandler
BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
07/26/22
07/26
20:25
07/26/22
20:25
TMUS

T-Mobile

$133.91 /

-0.62 (-0.46%)

, BMY

Bristol-Myers

$73.51 /

+0.68 (+0.93%)

, BA

Boeing

$155.81 /

-0.87 (-0.56%)

, ADP

ADP

$217.89 /

-0.39 (-0.18%)

, SHW

Sherwin-Williams

$254.36 /

-4.63 (-1.79%)

, GD

General Dynamics

$217.48 /

-1.32 (-0.60%)

, HUM

Humana

$491.17 /

-0.69 (-0.14%)

, BSX

Boston Scientific

$38.00 /

-0.02 (-0.05%)

, SHOP

Shopify

$31.54 /

-5.17 (-14.08%)

, KHC

Kraft Heinz

$38.62 /

+0.23 (+0.60%)

, HLT

Hilton

$120.40 /

-1.775 (-1.45%)

, ROK

Rockwell Automation

$219.15 /

-0.53 (-0.24%)

, TPX

Tempur Sealy

$24.17 /

-0.83 (-3.32%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include T-Mobile (TMUS), consensus 28c... Bristol Myers (BMY), consensus $1.82... Boeing (BA), consensus (16c)... ADP (ADP), consensus $1.46... Sherwing-Williams (SHW), consensus $2.78... General Dynamics (GD), consensus $2.72... Humana (HUM), consensus $7.67... Boston Scientific (BSX), consensus 42c... Shopify (SHOP), consensus 3c... Kraft Heinz (KHC), consensus 68c... Hilton (HLT), consensus $1.04... Rockwell Automation (ROK), consensus $2.39... Tempur Sealy (TPX), consensus 60c.

ShowHide Related Items >><<
TPX Tempur Sealy
$24.17 /

-0.83 (-3.32%)

TMUS T-Mobile
$133.91 /

-0.62 (-0.46%)

SHW Sherwin-Williams
$254.36 /

-4.63 (-1.79%)

SHOP Shopify
$31.54 /

-5.17 (-14.08%)

ROK Rockwell Automation
$219.15 /

-0.53 (-0.24%)

KHC Kraft Heinz
$38.62 /

+0.23 (+0.60%)

HUM Humana
$491.17 /

-0.69 (-0.14%)

HLT Hilton
$120.40 /

-1.775 (-1.45%)

GD General Dynamics
$217.48 /

-1.32 (-0.60%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BMY Bristol-Myers
$73.51 /

+0.68 (+0.93%)

BA Boeing
$155.81 /

-0.87 (-0.56%)

ADP ADP
$217.89 /

-0.39 (-0.18%)

TMUS T-Mobile
$133.91 /

-0.62 (-0.46%)

07/22/22 Barclays
AT&T downgraded to Equal Weight from Overweight at Barclays
07/20/22 Citi
T-Mobile price target raised to $160 from $156 at Citi
07/19/22 Deutsche Bank
T-Mobile price target raised to $190 from $185 at Deutsche Bank
07/14/22 RBC Capital
T-Mobile price target raised to $158 from $152 at RBC Capital
BMY Bristol-Myers
$73.51 /

+0.68 (+0.93%)

07/20/22 Canaccord
Canaccord starts Arcellx at Buy, sees 'best-in-class' potential
06/23/22 BMO Capital
Nuvalent initiated with an Outperform at BMO Capital
06/06/22 H.C. Wainwright
Turning Point Therapeutics downgraded to Neutral from Buy at H.C. Wainwright
06/05/22 BofA
BofA keeps Buy on Bristol-Myers, raises price target to $80
BA Boeing
$155.81 /

-0.87 (-0.56%)

07/18/22 Cowen
Cowen believes Aerospace and Defense quarterly results to be mixed
07/15/22 Benchmark
Boeing price target lowered to $200 from $250 at Benchmark
07/14/22 RBC Capital
Boeing price target lowered to $200 from $220 at RBC Capital
07/13/22 JPMorgan
Boeing price target lowered to $188 from $190 at JPMorgan
ADP ADP
$217.89 /

-0.39 (-0.18%)

07/20/22 Wolfe Research
ADP price target lowered to $210 from $235 at Wolfe Research
05/02/22 Mizuho
ADP price target raised to $250 from $235 at Mizuho
05/02/22 Barclays
ADP price target raised to $257 from $238 at Barclays
05/02/22 Citi
ADP price target raised to $230 from $212 at Citi
SHW Sherwin-Williams
$254.36 /

-4.63 (-1.79%)

07/18/22 Wells Fargo
Sherwin-Williams price target lowered to $270 from $285 at Wells Fargo
07/14/22 Mizuho
Sherwin-Williams price target lowered to $294 from $310 at Mizuho
07/13/22 BofA
BofA downgrades Sherwin-Williams to Neutral, sees limited catalysts
07/13/22 BofA
Sherwin-Williams downgraded to Neutral from Buy at BofA
GD General Dynamics
$217.48 /

-1.32 (-0.60%)

04/28/22 Susquehanna
General Dynamics price target raised to $285 from $280 at Susquehanna
03/29/22 Jefferies
Northrop among biggest beneficiaries of DoD budget request, says Jefferies
03/07/22 Wells Fargo
General Dynamics price target raised to $282 from $235 at Wells Fargo
02/04/22 Morgan Stanley
Morgan Stanley upgrades General Dynamics to Equal Weight on Gulfstream outlook
HUM Humana
$491.17 /

-0.69 (-0.14%)

07/14/22 Truist
Humana price target raised to $550 from $490 at Truist
07/05/22 Stifel
Stifel says 'logical to assume' Walgreens could look at 1Life Healthcare
06/16/22 Loop Capital
Loop starts Humana at Buy on brand and growing portfolio
06/16/22 Loop Capital
Humana initiated with a Buy at Loop Capital
BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

07/20/22 Truist
Boston Scientific price target lowered to $45 from $51 at Truist
07/06/22 Wolfe Research
Wolfe Research starts 'Goldilocks stock' Boston Scientific at Outperform
07/05/22 Wolfe Research
Boston Scientific initiated with an Outperform at Wolfe Research
07/05/22 Piper Sandler
Bottom in med tech shares is 'getting close,' says Piper Sandler
SHOP Shopify
$31.54 /

-5.17 (-14.08%)

07/26/22 Oppenheimer
Shopify assumed with an Outperform at Oppenheimer
07/26/22 Stifel
BigCommerce price target lowered to $23 from $35 at Stifel
07/26/22 Citi
Shopify price target lowered to $37 from $43.20 at Citi
07/18/22 Wells Fargo
Shopify price target lowered to $40 from $55 at Wells Fargo
KHC Kraft Heinz
$38.62 /

+0.23 (+0.60%)

07/26/22 Morgan Stanley
Walmart warning reinforces cautious view of packaged food, says Morgan Stanley
07/18/22 Deutsche Bank
Kraft Heinz price target lowered to $47 from $48 at Deutsche Bank
07/18/22 Mizuho
Kraft Heinz initiated with a Buy at Mizuho
06/22/22 BMO Capital
Kraft Heinz upgraded to Outperform from Market Perform at BMO Capital
HLT Hilton
$120.40 /

-1.775 (-1.45%)

07/11/22 Evercore ISI
Hilton assumed at Outperform from In Line at Evercore ISI
06/28/22 Barclays
Hilton initiated with an Equal Weight at Barclays
05/04/22 Deutsche Bank
Hilton price target raised to $141 from $136 at Deutsche Bank
02/22/22 Wells Fargo
Hilton price target raised to $160 from $147 at Wells Fargo
ROK Rockwell Automation
$219.15 /

-0.53 (-0.24%)

07/18/22 Mizuho
Rockwell Automation price target lowered to $200 from $215 at Mizuho
07/13/22 Deutsche Bank
Rockwell Automation price target lowered to $212 from $250 at Deutsche Bank
07/13/22 Deutsche Bank
Rockwell Automation named short-term sell idea at Deutsche Bank
07/12/22 Wells Fargo
Rockwell Automation price target lowered to $189 from $190 at Wells Fargo
TPX Tempur Sealy
$24.17 /

-0.83 (-3.32%)

07/20/22 UBS
Tempur Sealy price target lowered to $35 from $45 at UBS
06/01/22 Piper Sandler
Tempur Sealy downgraded to Neutral from Overweight at Piper Sandler
04/12/22 Loop Capital
Tempur Sealy price target lowered to $28 from $35 at Loop Capital
04/06/22 Raymond James
Tempur Sealy price target lowered to $38 from $45 at Raymond James
TPX Tempur Sealy
$24.17 /

-0.83 (-3.32%)

TMUS T-Mobile
$133.91 /

-0.62 (-0.46%)

SHW Sherwin-Williams
$254.36 /

-4.63 (-1.79%)

SHOP Shopify
$31.54 /

-5.17 (-14.08%)

ROK Rockwell Automation
$219.15 /

-0.53 (-0.24%)

KHC Kraft Heinz
$38.62 /

+0.23 (+0.60%)

HUM Humana
$491.17 /

-0.69 (-0.14%)

HLT Hilton
$120.40 /

-1.775 (-1.45%)

GD General Dynamics
$217.48 /

-1.32 (-0.60%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BMY Bristol-Myers
$73.51 /

+0.68 (+0.93%)

BA Boeing
$155.81 /

-0.87 (-0.56%)

ADP ADP
$217.89 /

-0.39 (-0.18%)

  • 18
    Nov
  • 09
    Sep
TMUS T-Mobile
$133.91 /

-0.62 (-0.46%)

SHOP Shopify
$31.54 /

-5.17 (-14.08%)

KHC Kraft Heinz
$38.62 /

+0.23 (+0.60%)

HUM Humana
$491.17 /

-0.69 (-0.14%)

HLT Hilton
$120.40 /

-1.775 (-1.45%)

GD General Dynamics
$217.48 /

-1.32 (-0.60%)

BMY Bristol-Myers
$73.51 /

+0.68 (+0.93%)

BA Boeing
$155.81 /

-0.87 (-0.56%)

TPX Tempur Sealy
$24.17 /

-0.83 (-3.32%)

TMUS T-Mobile
$133.91 /

-0.62 (-0.46%)

SHW Sherwin-Williams
$254.36 /

-4.63 (-1.79%)

SHOP Shopify
$31.54 /

-5.17 (-14.08%)

ROK Rockwell Automation
$219.15 /

-0.53 (-0.24%)

KHC Kraft Heinz
$38.62 /

+0.23 (+0.60%)

HUM Humana
$491.17 /

-0.69 (-0.14%)

HLT Hilton
$120.40 /

-1.775 (-1.45%)

GD General Dynamics
$217.48 /

-1.32 (-0.60%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BMY Bristol-Myers
$73.51 /

+0.68 (+0.93%)

BA Boeing
$155.81 /

-0.87 (-0.56%)

ADP ADP
$217.89 /

-0.39 (-0.18%)

TPX Tempur Sealy
$24.17 /

-0.83 (-3.32%)

TMUS T-Mobile
$133.91 /

-0.62 (-0.46%)

SHW Sherwin-Williams
$254.36 /

-4.63 (-1.79%)

SHOP Shopify
$31.54 /

-5.17 (-14.08%)

KHC Kraft Heinz
$38.62 /

+0.23 (+0.60%)

HLT Hilton
$120.40 /

-1.775 (-1.45%)

BSX Boston Scientific
$38.00 /

-0.02 (-0.05%)

BMY Bristol-Myers
$73.51 /

+0.68 (+0.93%)

BA Boeing
$155.81 /

-0.87 (-0.56%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.